Original Research
Published on 13 Mar 2024
Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362325
- 725 views
Type at least 3 characters
554 articles
Articles
Review
Published on 07 Mar 2024
The role of inflammation in silicosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362509
- 1,138 views
Correction
Published on 07 Mar 2024
Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1365790
- 478 views
Original Research
Published on 23 Feb 2024
A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1310286
- 1,633 views
- 1 citation
Original Research
Published on 21 Feb 2024
CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in the murine model of the acute respiratory distress syndrome
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1351655
- 1,122 views
Original Research
Published on 13 Feb 2024
Elucidating shared biomarkers in gastroesophageal reflux disease and idiopathic pulmonary fibrosis: insights into novel therapeutic targets and the role of angelicae sinensis radix
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1348708
- 1,810 views
Original Research
Published on 07 Feb 2024
Risk of potential hepatotoxicity from pirfenidone or nintedanib in patients with idiopathic pulmonary fibrosis: results of a retrospective analysis of a large insurance database in Taiwan
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1309712
- 1,143 views
Original Research
Published on 10 Jan 2024
Therapeutic drug monitoring of corticosteroids/β2-agonists in the hair of patients with asthma: an open-label feasibility study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1339835
- 664 views
Review
Published on 08 Jan 2024
Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1315540
- 1,850 views
Case Report
Published on 08 Jan 2024
Case report: Fibrotic interstitial lung disease as the initial manifestation of hereditary pulmonary alveolar proteinosis caused by CSF2RB mutation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1252193
- 885 views
Original Research
Published on 12 Dec 2023
Efficacy and safety of combination therapy with pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1301923
- 2,187 views
- 2 citations
Review
Published on 11 Dec 2023
Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1277284
- 1,517 views
- 2 citations
Editorial
Published on 06 Dec 2023
Editorial: Novel therapeutic strategies for the treatment of respiratory diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1340116
- 580 views
Original Research
Published on 06 Dec 2023
Vitamin E stabilizes iron and mitochondrial metabolism in pulmonary fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1240829
- 1,667 views
Review
Published on 06 Dec 2023
The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1330518
- 1,964 views
Review
Published on 06 Dec 2023
Potential role of irisin in lung diseases and advances in research
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1307651
- 1,947 views